Loading organizations...

§ Venture Capital · Mont-saint-guibert, Brabant Wallon, Belgium
An angel fund and early-stage investment group providing seed capital and support for startups and entrepreneurs in Belgium.
BAMS Angel Fund operates as an early-stage investment vehicle, primarily deploying capital into nascent companies. It provides strategic funding for rounds typically between EUR 1 million and 4 million, specifically targeting seed-stage and Series A. This financial support accelerates the growth trajectories of promising startups by offering essential capital at critical junctures. The fund’s core offering is financial backing paired with a supportive network.
Established in Mont-Saint-Guibert, Belgium, BAMS Angel Fund was formed from the understanding that structured capital and experienced guidance are critical for startups. The fund emerged to formalize and amplify individual angel investment activities, supporting the regional entrepreneurial ecosystem. This initiative bridges funding gaps for innovative, emerging enterprises by providing a systematic investment platform.
BAMS Angel Fund supports early-stage companies seeking capital and mentorship, primarily within the European market. Its vision centers on fostering innovation and accelerating the development of promising ventures across various sectors. By identifying and nurturing high-potential startups, the fund contributes to a vibrant entrepreneurial landscape, driving long-term economic growth and value creation.
BAMS Angel Fund has 1 tracked investment across 1 company. The latest tracked deal is $10.4M Grant / Series D in Bone Therapeutics in January 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 28, 2013 | Bone Therapeutics | $10.4M Grant / Series D | — | Life Sciences Research Partners, Nausicaa Ventures, Sambrinvest, Sriw |